These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30019272)

  • 1. Mechanistic implication of decreased plasma atrial natriuretic peptide level for transient rise in the atrial capture threshold early after ICD or CRT-D implantation.
    Ogawa K; Yoshida K; Uehara Y; Ebine M; Kimata A; Nishina H; Takeyasu N; Noguchi Y; Ieda M; Aonuma K; Nogami A
    J Interv Card Electrophysiol; 2018 Oct; 53(1):131-140. PubMed ID: 30019272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
    Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
    Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome.
    Horie H; Tsutamoto T; Minai K; Hayashi M; Kito O; Kinoshita M
    Jpn Circ J; 2000 Dec; 64(12):965-70. PubMed ID: 11194292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underrecognized entity of the transient rise in the atrial capture threshold early after dual-chamber pacemaker implantation.
    Uehara Y; Yoshida K; Kimata A; Ogawa K; Abe D; Tsumagari Y; Tsuneoka H; Yui Y; Ito Y; Ebine M; Takeyasu N; Aonuma K; Nogami A
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1396-1404. PubMed ID: 29139149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
    Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
    Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy.
    Smit MD; Maass AH; Hillege HL; Wiesfeld AC; Van Veldhuisen DJ; Van Gelder IC
    Eur J Heart Fail; 2011 May; 13(5):543-50. PubMed ID: 21330294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation analysis of atrial natriuretic peptide concentration, echocardiographic left atrial and left ventricular dimensions, and renal function parameters in patients after permanent pacemaker implantation.
    Sielski J; Janion M; Gawor Z; Ciuraszkiewicz K; Sielska MR
    Cardiol J; 2009; 16(2):157-63. PubMed ID: 19387964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy.
    Lellouche N; De Diego C; Cesario DA; Vaseghi M; Horowitz BN; Mahajan A; Wiener I; Boyle NG; Fonarow GC; Shivkumar K
    Am J Cardiol; 2007 Jan; 99(2):242-6. PubMed ID: 17223426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma cardiac natriuretic peptide as a biological marker of recurrence of atrial fibrillation in elderly people].
    Mabuchi N; Tsutamoto T; Maeda K; Masahiko K
    Nihon Ronen Igakkai Zasshi; 2000 Jul; 37(7):535-40. PubMed ID: 11031826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma norepinephrine level and sick sinus syndrome in patients with lone atrial fibrillation.
    Yoshida K; Kaneshiro T; Ito Y; Kimata A; Koda N; Hiraya D; Baba M; Misaki M; Takeyasu N; Yamaguchi I; Aonuma K
    Heart; 2015 Jul; 101(14):1133-8. PubMed ID: 25968056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).
    Brenyo A; Link MS; Barsheshet A; Moss AJ; Zareba W; Wang PJ; McNitt S; Huang D; Foster E; Estes M; Solomon SD; Goldenberg I
    J Am Coll Cardiol; 2011 Oct; 58(16):1682-9. PubMed ID: 21982313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.
    Ruwald AC; Kutyifa V; Ruwald MH; Solomon S; Daubert JP; Jons C; Brenyo A; McNitt S; Do D; Tanabe K; Al-Ahmad A; Wang P; Moss AJ; Zareba W
    Eur Heart J; 2015 Feb; 36(7):440-8. PubMed ID: 25112662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma natriuretic peptide levels and daily physical activity in patients with pacemaker implantation.
    Wu X; Seino Y; Ogura H; Fukuma N; Katoh T; Takano T
    Jpn Heart J; 2001 Jul; 42(4):471-82. PubMed ID: 11693283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.